Table 2.
Patient # | Clinical Stage at Baseline | Histology | Pathologic Stage |
---|---|---|---|
| |||
2 | cT2 | UC | pT0N0 |
3 | cT2¥ | UC | pT0N0 |
4 | cT2¥ | UC | pT4aN0 |
5 | cT4a | UC | pT0N0 |
8 | cT3b, 3-D mass on EUA | UC with squamous differentiation | pT0N0 |
9 | cT2¥ | UC with plasmacytoid features | pT4N2 |
10 | cT2 | UC | pT1N0 |
11 | cT4a¥ | UC | pT1N0 |
12 | cT2¥ | UC with sarcomatoid features | pT0N0 |
13 | cT3b, 3-D mass on EUA | UC | pT2aN0 |
15 | cT3b, 3-D mass on EUA | UC | pTaN0 |
16 | cT3b, 3-D mass on EUA | UC | pT2N0 |
18 | cT2 | UC | pT3bN1 |
22 | cT2 | UC | pT2N0 |
23 | cT3b, 3-D mass on EUA | UC with squamous differentiation | pT0N0 |
24 | cT3b, 3-D mass on EUA | UC | pTisN0 |
25 | cT3b, 3-D mass on EUA | UC | pTis & TaN0 |
31 | cT2 | UC with focal micropapillary features | pT4aN2 |
32 | cT3b, 3-D mass on EUA | Small cell carcinoma | pT2N1 |
34 | cT2 | UC | pT2N0 |
35 | cT2¥ | UC | pT2N1 |
36 | cT3b, 3-D mass on EUA | UC | pT0N0 |
37 | cT1* | UC with focal micropapillary features | pT0N0 |
38 | cT3b | UC | pT1N0 |
cT1 with high grade histology, diffuse involvement of disease throughout the bladder and high-risk feature of micropapillary disease
These patients had a second TURBT to further evaluate disease status prior to cystectomy
UC: urothelial carcinoma